Keyphrases
Tumor Growth
100%
Cell Malignancy
100%
Mast Cells
100%
Cancer Cells
100%
Radiation-induced Apoptosis
100%
Systemic Mastocytosis
100%
CD34+ Cells
100%
Biliary Tract Cancer
100%
Early Growth Response Protein 1 (EGR1)
100%
Mast Cell Leukemia
66%
Intrahepatic Cholangiocarcinoma (iCCA)
66%
Extrahepatic Cholangiocarcinoma
66%
Gallbladder Cancer
66%
Malignancy
66%
KIT Protein
33%
Mast Cell Neoplasm
33%
Disease Biology
33%
Histological Subtypes
33%
Complete Surgical Resection
33%
Paucity
33%
Isocitrate Dehydrogenase 1 (IDH1)
33%
Treatment Options
33%
Biliary Tree
33%
Autophosphorylation
33%
Hematopoietic Precursors
33%
Clinical Outcomes
33%
Advanced or Metastatic
33%
Clinical Trials
33%
Advanced Disease
33%
Next-generation Sequencing
33%
Effective Treatment
33%
Systemic Chemotherapy
33%
Apoptosis
33%
Epithelial Cells
33%
Dismal Prognosis
33%
ATP Binding Site
33%
KIT mutation
33%
Site of Origin
33%
Emerging Knowledge
33%
HER2 Pathway
33%
Functional Test
33%
Umbilical Cord Blood
33%
FGFR2 Fusion
33%
Mitogen-activated Protein Kinase
33%
Molecular Signature
33%
Gene of Interest
33%
Anatomic Site
33%
Targeted Therapeutics
33%
EGFR Pathway
33%
Bone Marrow
33%
Medicine and Dentistry
Biological Product
100%
Biliary Duct Cancer
100%
Programmed Cell Death
100%
Tumor Progression
100%
Cholangiocarcinoma
100%
Cancer Cell
100%
Diseases
75%
Gallbladder Cancer
50%
Biliary Tract Cancer
50%
Cancer
50%
Epithelial Cell
41%
Hippocampus
33%
Neoplasm
33%
Ionizing Radiation
33%
Radiation Therapy
33%
Fibroblast Growth Factor Receptor 2
25%
Next Generation Sequencing
25%
Epidermal Growth Factor Receptor
25%
Metastatic Carcinoma
25%
Clinical Trial
25%
Mitogen-Activated Protein Kinase
25%
Biological Marker
25%
Surgery
25%
Malignant Neoplasm
16%
Quality of Life
16%
Malabsorption
16%
Cancer Cell Line
16%
Toxicity
16%
Plicamycin
16%
Early Growth Response Factor 1
16%
Disorders of Higher Cerebral Function
16%
Promoter Region
16%
Short Hairpin RNA
16%
Glioma Cell
16%
Radiation Response
16%
Protein P53
16%
Small Intestine
16%
Therapeutic Window
16%
Colorectal Carcinoma
16%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Bile Duct Carcinoma
100%
Tumor Growth
100%
Biliary Tract Cancer
100%
Biological Product
100%
Diseases
75%
Ionizing Radiation
66%
Neoplasm
66%
Gallbladder Cancer
50%
Toxicity
33%
Protein P53
33%
Mithramycin
33%
Disorders of Higher Cerebral Function
33%
Short Hairpin RNA
33%
Malabsorption
33%
Knockout Mouse
33%
Therapeutic Window
33%
Early Growth Response Factor 1
33%
Colorectal Carcinoma
33%
Chemotherapy
25%
Metastasis
25%
Clinical Trial
25%
Biological Marker
25%
Fibroblast Growth Factor Receptor 2
25%
Epidermal Growth Factor Receptor
25%